Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)

• This is a special issue of “Metabolism” dedicated to nonalcoholic fatty liver disease. • Experts in the field provide an overview of recent progress and developments in NAFLD and offer their expert opinion on future directions. • NAFLD remains a highly prevalent disease without an approved treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Polyzos, Stergios A., Mantzoros, Christos S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372254/
https://www.ncbi.nlm.nih.gov/pubmed/32707055
http://dx.doi.org/10.1016/j.metabol.2020.154318
_version_ 1783561275729510400
author Polyzos, Stergios A.
Mantzoros, Christos S.
author_facet Polyzos, Stergios A.
Mantzoros, Christos S.
author_sort Polyzos, Stergios A.
collection PubMed
description • This is a special issue of “Metabolism” dedicated to nonalcoholic fatty liver disease. • Experts in the field provide an overview of recent progress and developments in NAFLD and offer their expert opinion on future directions. • NAFLD remains a highly prevalent disease without an approved treatment.
format Online
Article
Text
id pubmed-7372254
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73722542020-07-21 Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD) Polyzos, Stergios A. Mantzoros, Christos S. Metabolism Article • This is a special issue of “Metabolism” dedicated to nonalcoholic fatty liver disease. • Experts in the field provide an overview of recent progress and developments in NAFLD and offer their expert opinion on future directions. • NAFLD remains a highly prevalent disease without an approved treatment. Elsevier Inc. 2020-10 2020-07-21 /pmc/articles/PMC7372254/ /pubmed/32707055 http://dx.doi.org/10.1016/j.metabol.2020.154318 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Polyzos, Stergios A.
Mantzoros, Christos S.
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title_full Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title_fullStr Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title_full_unstemmed Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title_short Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
title_sort making progress in nonalcoholic fatty liver disease (nafld) as we are transitioning from the era of nafld to dys-metabolism associated fatty liver disease (dafld)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372254/
https://www.ncbi.nlm.nih.gov/pubmed/32707055
http://dx.doi.org/10.1016/j.metabol.2020.154318
work_keys_str_mv AT polyzosstergiosa makingprogressinnonalcoholicfattyliverdiseasenafldaswearetransitioningfromtheeraofnafldtodysmetabolismassociatedfattyliverdiseasedafld
AT mantzoroschristoss makingprogressinnonalcoholicfattyliverdiseasenafldaswearetransitioningfromtheeraofnafldtodysmetabolismassociatedfattyliverdiseasedafld

Ejemplares similares